Zinilisib
Zinilisib (Zinilisibum) is a PI3K inhibitor. Zinilisib potently inhibits the phosphorylation of AKT in cells expressing mutant PI3KαH1047R and wild-type PI3Kα, with IC50 values of 1-500 nM and 2-15 μM, respectively. Zinilisib can be used in breast cancer-related research.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3031974-57-6
- Formel: C26H29F3N4O3
- Molecular Weight:502.53
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:T47D cells expressing mutant PI3Kα (H1047R), SKBR3 cells expressing wild-type PI3Kα
-
Concentration:10-point dilution series
-
Incubation Time:72 h
-
Result:Inhibited proliferation of T47D cells with an average EC50 in the range of 1 nM to 500 nM.
Inhibited proliferation of SKBR3 cells with an average EC50 in the range of 2 μM to 15 μM.
Chemical Information
-
CAS. Nr. 3031974-57-6
-
Molecular Weight 502.53
-
Formel C26H29F3N4O3
-
SMILES
OC(C(C=CC=C1)=C1N[C@@H](C2=C3C(C(N(C(N4CCN(CC4)CC(F)(F)F)=C3)C)=O)=CC(C)=C2)C)=O
-
Synonyms
zinilisibum
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)